PILA PHARMA AB (publ) (FN STO: PILA), an innovative biotech company developing novel oral drugs for treatment of obesity and diabetes based on TRPV1 inhibition, informs investors and others with inter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback